|
Market Closed -
Nasdaq Stockholm
12:00:00 2026-09-11 EDT
|
5-day change | 1st Jan Change | ||
| 1.848 SEK | -2.63% |
|
+8.07% | -6.19% |
| 09-03 | Irlab CEO Kristina Torfgaard to step down in 2027 | FW |
| 09-03 | Irlab CEO Kristina Torfgaard wants to step down | FW |
EPS & Dividend: IRLAB Therapeutics AB
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Dividend per Share 2 | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - |
| EPS 2 | -1.922 | 1 | -2.188 | -3.429 | -1.603 | -1.642 |
| Distribution rate | - | - | - | - | - | - |
| Reference price 2 | 42.000 | 44.000 | 38.300 | 7.500 | 10.750 | 1.970 |
| Nbr of stocks (in thousands) | 51,748 | 51,748 | 51,868 | 51,868 | 51,868 | 84,938 |
| Announcement Date | 4/15/21 | 4/8/22 | 4/29/24 | 4/29/24 | 4/25/25 | 4/29/26 |
1SEK in Million2SEK
Estimates
Past dividends: IRLAB Therapeutics AB
| 2026-06-08 | Ex-dividend date - 0.97854 SEK | 00:00 |
Upcoming Events: IRLAB Therapeutics AB
| 2026-11-13 | Earnings release | Q3 2026 | |
| 2027-02-23 | Earnings release | Annual 2026 | Day |
| Dividend Yield (Y) | Dividend Yield (Y+1) | P/E (Y) | Price to Book (Y) | EV / Sales (Y) | ||
|---|---|---|---|---|---|---|
 | 0.62% | 0.69% | 31.77x | 20.16x | 11.54x | |
| 2.02% | 2.12% | 29.54x | - | - | |
| 2.67% | 2.8% | 32.92x | -468.23x | 7.63x | |
| 2.91% | 2.98% | 18.71x | 6.85x | 4.57x | |
| 3.21% | 3.35% | 19.41x | 5.51x | 5.08x | |
| 2.11% | 2.25% | 20.34x | 4.55x | 4.19x | |
| 2.67% | 2.82% | 23.87x | 18.03x | 6.3x | |
| 4.08% | 4.07% | 12.3x | 5.22x | 4.48x | |
| 2.29% | 2.33% | -43.47x | 10.7x | 6.35x | |
| Average | 2.51% | 2.6% | 16.16x | -49.65x | 6.27x | |
| Weighted average by Cap. | 2.05% | 2.14% | 23.19x | -63.27x | 7.72x |
Annual Profit -
Select your edition
All financial news and data tailored to specific country editions
